Open source and AI from a community-based intellectual property perspective
We recently had the opportunity to speak with Keith Bergelt, the CEO of Open Invention Network (OIN). OIN is the largest patent non-aggression community in history and the forerunner to many other organizations that have been formed to collectively shield companies...
Federal Circuit lowers barrier for ITC patent enforcement: a win for small biotech firms
In an important decision that has significant implications for patent enforcement in the biotherapeutic and cell culture arts, the Federal Circuit has reaffirmed the International Trade Commission’s (ITC) authority to block the importation of infringing. The ruling in...
Clarivate reveals Top 100 Global Innovators 2025
The Top 100 organizations generate $4.6 trillion in annual revenues, representing 4.4% of the global economy Clarivate Plc, a leading global provider of transformative intelligence, today revealed its 2025 ranked list of Top 100 Global Innovators – the organizations...
Letters Rogatory: a valuable tool for the collection of evidence across borders
The case involves a patent dispute between Pfizer Inc. and its subsidiaries (FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., and Wyeth LLC) (Petitioners) against Softgel Healthcare Private Limited (Respondent), an Indian company. The dispute centers around the alleged...
New continuation application fees: why and at what cost?
Earlier this year, the US Patent and Trademark Office (USPTO) instituted new fees related to the filing of continuation patent applications. As a refresher, a continuation application is a second or subsequent patent application filing that claims the benefit of an...
EUIPO’s 5th IP Case Law Conference: an inside look
We were delighted to attend the EUIPO’s 5th IP Case Law Conference held in Alicante on the 29-30 of April 2024 – special thanks to EUIPO for the invitation and exceptional hospitality throughout the conference. Following a warm welcome from Master of Ceremony Thomas...
Legal dispute redefining COVID-19 vaccine patents and future of mRNA tech
The race for a COVID-19 vaccine in 2020 was a global effort, but the aftermath has seen a bitter legal battle erupt between pharmaceutical giants. In August 2022, Moderna, a pioneer in messenger RNA (mRNA) technology, launched a lawsuit against Pfizer and BioNTech,...
Delhi High Court awards Ericsson $29 million in SEP case
On 28 March 2024, the Delhi High Court concluded a decade-long litigation between Telefonaktiebolaget LM Ericsson (Ericsson) and Lava Intl. Ltd (Lava) by delivering a landmark judgment that Lava infringed Ericsson’s eight Standard Essential Patents (SEPs) relating to...
Celebrating World IP Day: thoughts from our Editorial Board
As World Intellectual Property Day approaches on 26 April, we asked our Editorial Board their thoughts on this year's focus: 'IP and the SDGs: Building our common future with innovation and creativity.' Established by the United Nations in 2015, the Sustainable...
USPTO issues guidance on use of AI tools by patent and trademark practitioners
The USPTO recognizes that practitioners are increasingly using AI tools to prepare and prosecute patent and trademark applications. Therefore, to “cabin the risks” arising from the use of AI, on April 11, 2024, the USPTO issued guidance on the use of AI tools....
IP and tourism: navigating a path to success in honor of World IP Day 2024
World IP Day is April 26, 2024, and the theme for this year is “IP and the SDGs (Sustainable Development Goals): Building our common future with innovation and creativity.” One often overlooked topic is IP and its role in sustainable tourism. Understanding the...
USPTO set for new fee structure for 2025
The United States Patent and Trademark Office (USPTO) is poised for a pivotal transformation in its fee structure, slated for fiscal year 2025. This overhaul, far from being a mere procedural update, represents a fundamental shift poised to redefine the landscape of...
EPO broadens ability to protect known ‘substances or compositions’ in medicine
In decision T 1252/20, the European Patent Office (EPO) has broadened the ability to protect known substances or compositions, for use in medicine. In the UK and Europe, patent claims to ‘methods’ are not permitted if the method is surgical, therapeutic, or...
The largest patent prosecution firms in Mexico
The intellectual property scene in Mexico experienced significant growth from 2018 to 2022. According to data from IP Pilot, a total of 89 patent prosecution firms in Mexico handled 72,632 patent filings during this period. Following the pandemic, the market quickly...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.